BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights Pharmaceutical Investing
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myeloma Pharmaceutical Investing
Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency Pharmaceutical Investing
The Gummy Project Announces That Its Gummies Land on North America's Largest Passenger Ferry Line Life Science Investing
CORRECTING and REPLACING Cybin Announces Up to USD$35 Million At-The-Market Equity Program Life Science Investing
Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights Life Science Investing
AMGEN DATA AT WCLC 2022 HIGHLIGHTS POTENTIAL TO DELIVER TRANSFORMATIVE MEDICINES FOR HISTORICALLY DIFFICULT-TO-TREAT LUNG CANCERS Market News
